Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
The EMBO Journal|September 15, 2011
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancerBiswajyoti Sahu, Marko Laakso, Kristian Ovaska, et al.
Molecular and Cellular Biology|July 4, 2012
c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cellsBenny Björkblom, Artur Padzik, Hasan Mohammad, et al.
Theranostics|November 8, 2017
Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related ChangesMaija Puhka, Maarit Takatalo, Maria-Elisa Nordberg, et al.
Gynecologic Oncology|January 21, 2017
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cellsUlla-Maija Haltia, Noora Andersson, Bhagwan Yadav, et al.
The Journal of Nutrition|December 31, 2020
Genetic Risk Score for Serum 25-Hydroxyvitamin D Concentration Helps to Guide Personalized Vitamin D Supplementation in Healthy Finnish AdultsRiitta J Sallinen, Olga Dethlefsen, Sanni Ruotsalainen, et al.
International Journal of Cancer|November 1, 2014
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditionsKhalid Saeed, Päivi Östling, Mari Björkman, et al.
Nature Cell Biology|September 28, 2011
SHARPIN is an endogenous inhibitor of β1-integrin activationJuha K Rantala, Jeroen Pouwels, Teijo Pellinen, et al.
Oncotarget|June 9, 2016
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signalingDiede Brunen, María José García-Barchino, Disha Malani, et al.
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Blood Advances|January 23, 2020
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survivalOscar Brück, Olli Dufva, Helena Hohtari, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
The EMBO Journal|September 15, 2011
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancerBiswajyoti Sahu, Marko Laakso, Kristian Ovaska, et al.
Molecular and Cellular Biology|July 4, 2012
c-Jun N-terminal kinase phosphorylation of MARCKSL1 determines actin stability and migration in neurons and in cancer cellsBenny Björkblom, Artur Padzik, Hasan Mohammad, et al.
Theranostics|November 8, 2017
Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related ChangesMaija Puhka, Maarit Takatalo, Maria-Elisa Nordberg, et al.
Gynecologic Oncology|January 21, 2017
Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cellsUlla-Maija Haltia, Noora Andersson, Bhagwan Yadav, et al.
The Journal of Nutrition|December 31, 2020
Genetic Risk Score for Serum 25-Hydroxyvitamin D Concentration Helps to Guide Personalized Vitamin D Supplementation in Healthy Finnish AdultsRiitta J Sallinen, Olga Dethlefsen, Sanni Ruotsalainen, et al.
International Journal of Cancer|November 1, 2014
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditionsKhalid Saeed, Päivi Östling, Mari Björkman, et al.
Nature Cell Biology|September 28, 2011
SHARPIN is an endogenous inhibitor of β1-integrin activationJuha K Rantala, Jeroen Pouwels, Teijo Pellinen, et al.
Oncotarget|June 9, 2016
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signalingDiede Brunen, María José García-Barchino, Disha Malani, et al.
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Blood Advances|January 23, 2020
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survivalOscar Brück, Olli Dufva, Helena Hohtari, et al.
Pageof 19